Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Minimal Residual Disease (MRD) Testing industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Mission Bio
Guardant Health
Asuragen
Quest Diagnostics
NeoGenomics , Inc
NeoGenomics Laboratories
ARUP Laboratories
Sysmex Corporation
Opko Health
Bio-Rad Laboratories
By Type:
Flow Cytometry
Liquid Biopsies
Polymerase Chain Reaction (PCR)
Next-Generation Sequencing (NGS)
By Application:
Diagnostic Laboratories
Research Institutions
Specialty Clinics and Hospitals
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Minimal Residual Disease (MRD) Testing Market Overview 2018-2029
-
1.1 China Minimal Residual Disease (MRD) Testing Industry Development Overview
-
1.2 China Minimal Residual Disease (MRD) Testing Industry Development History
-
1.3 China Minimal Residual Disease (MRD) Testing Industry Market Size (2018-2029)
-
1.4 China Minimal Residual Disease (MRD) Testing Market Analysis by Type from Production Side
-
1.4.1 China Minimal Residual Disease (MRD) Testing Production Volume, Production Value and Growth Rate of Flow Cytometry (2018-2029)
-
1.4.2 China Minimal Residual Disease (MRD) Testing Production Volume, Production Value and Growth Rate of Liquid Biopsies (2018-2029)
-
1.4.3 China Minimal Residual Disease (MRD) Testing Production Volume, Production Value and Growth Rate of Polymerase Chain Reaction (PCR) (2018-2029)
-
1.4.4 China Minimal Residual Disease (MRD) Testing Production Volume, Production Value and Growth Rate of Next-Generation Sequencing (NGS) (2018-2029)
-
1.5 China Minimal Residual Disease (MRD) Testing Market Analysis by Application from Consumption End
-
1.5.1 China Minimal Residual Disease (MRD) Testing Sales Volume, Sales Value and Growth Rate of Diagnostic Laboratories (2018-2029)
-
1.5.2 China Minimal Residual Disease (MRD) Testing Sales Volume, Sales Value and Growth Rate of Research Institutions (2018-2029)
-
1.5.3 China Minimal Residual Disease (MRD) Testing Sales Volume, Sales Value and Growth Rate of Specialty Clinics and Hospitals (2018-2029)
-
1.6 China Minimal Residual Disease (MRD) Testing Market Analysis by Region
-
1.6.1 North China Minimal Residual Disease (MRD) Testing Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Minimal Residual Disease (MRD) Testing Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Minimal Residual Disease (MRD) Testing Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Minimal Residual Disease (MRD) Testing Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Minimal Residual Disease (MRD) Testing Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Minimal Residual Disease (MRD) Testing Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Minimal Residual Disease (MRD) Testing Market Size and Growth Rate from 2018-2029
Chapter 2 China Minimal Residual Disease (MRD) Testing Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Minimal Residual Disease (MRD) Testing Market Status and Competition at home and abroad in 2023
-
2.2.2 China Minimal Residual Disease (MRD) Testing Market Status and Competition Analysis in 2023
-
2.2.3 China Minimal Residual Disease (MRD) Testing Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Minimal Residual Disease (MRD) Testing Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Minimal Residual Disease (MRD) Testing Industry Development
Chapter 3 Minimal Residual Disease (MRD) TestingIndustry Chain Analysis
-
3.1 Minimal Residual Disease (MRD) Testing Industry Chain
-
3.2 Minimal Residual Disease (MRD) Testing Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Minimal Residual Disease (MRD) Testing Market
-
3.3 Minimal Residual Disease (MRD) Testing Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Minimal Residual Disease (MRD) Testing Market
Chapter 4 China Minimal Residual Disease (MRD) Testing Market, by Type
-
4.1 China Minimal Residual Disease (MRD) Testing Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Minimal Residual Disease (MRD) Testing Total Production Volume and Growth Rate from Production Side
-
4.5 China Minimal Residual Disease (MRD) Testing Production Volume and Growth Rate, by Type
-
4.5.1 China Minimal Residual Disease (MRD) Testing Production Volume and Growth Rate of Flow Cytometry
-
4.5.2 China Minimal Residual Disease (MRD) Testing Production Volume and Growth Rate of Liquid Biopsies
-
4.5.3 China Minimal Residual Disease (MRD) Testing Production Volume and Growth Rate of Polymerase Chain Reaction (PCR)
-
4.5.4 China Minimal Residual Disease (MRD) Testing Production Volume and Growth Rate of Next-Generation Sequencing (NGS)
Chapter 5 China Minimal Residual Disease (MRD) Testing Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Minimal Residual Disease (MRD) Testing Total Market Size and Growth Rate from Consumption End
-
5.5 China Minimal Residual Disease (MRD) Testing Market Size and Growth Rate, by Application
-
5.5.1 China Minimal Residual Disease (MRD) Testing Market Size and Growth Rate of Diagnostic Laboratories
-
5.5.2 China Minimal Residual Disease (MRD) Testing Market Size and Growth Rate of Research Institutions
-
5.5.3 China Minimal Residual Disease (MRD) Testing Market Size and Growth Rate of Specialty Clinics and Hospitals
Chapter 6 China Minimal Residual Disease (MRD) Testing Market, by Region
-
6.1 China Minimal Residual Disease (MRD) Testing Production Volume and Production Value, by Region
-
6.2 China Minimal Residual Disease (MRD) Testing Sales Volume and Sales Value, by Region
Chapter 7 North China Minimal Residual Disease (MRD) Testing Market Analysis
-
7.1 North China Minimal Residual Disease (MRD) Testing Market, by Type
-
7.2 North China Minimal Residual Disease (MRD) Testing Market, by Application
Chapter 8 Central China Minimal Residual Disease (MRD) Testing Market Analysis
-
8.1 Central China Minimal Residual Disease (MRD) Testing Market, by Type
-
8.2 Central China Minimal Residual Disease (MRD) Testing Market, by Application
Chapter 9 South China Minimal Residual Disease (MRD) Testing Market Analysis
-
9.1 South China Minimal Residual Disease (MRD) Testing Market, by Type
-
9.2 South China Minimal Residual Disease (MRD) Testing Market, by Application
Chapter 10 East China Minimal Residual Disease (MRD) Testing Market Analysis
-
10.1 East China Minimal Residual Disease (MRD) Testing Market, by Type
-
10.2 East China Minimal Residual Disease (MRD) Testing Market, by Application
Chapter 11 Northeast China Minimal Residual Disease (MRD) Testing Market Analysis
-
11.1 Northeast China Minimal Residual Disease (MRD) Testing Market, by Type
-
11.2 Northeast China Minimal Residual Disease (MRD) Testing Market, by Application
Chapter 12 Southwest China Minimal Residual Disease (MRD) Testing Market Analysis
-
12.1 Southwest China Minimal Residual Disease (MRD) Testing Market, by Type
-
12.2 Southwest China Minimal Residual Disease (MRD) Testing Market, by Application
Chapter 13 Northwest China Minimal Residual Disease (MRD) Testing Market Analysis
-
13.1 Northwest China Minimal Residual Disease (MRD) Testing Market, by Type
-
13.2 Northwest China Minimal Residual Disease (MRD) Testing Market, by Application
Chapter 14 Company Profiles
-
14.1 Mission Bio
-
14.1.1 Mission Bio Company Profile
-
14.1.2 Mission Bio Minimal Residual Disease (MRD) Testing Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Guardant Health
-
14.2.1 Guardant Health Company Profile
-
14.2.2 Guardant Health Minimal Residual Disease (MRD) Testing Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Asuragen
-
14.3.1 Asuragen Company Profile
-
14.3.2 Asuragen Minimal Residual Disease (MRD) Testing Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Quest Diagnostics
-
14.4.1 Quest Diagnostics Company Profile
-
14.4.2 Quest Diagnostics Minimal Residual Disease (MRD) Testing Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 NeoGenomics , Inc
-
14.5.1 NeoGenomics , Inc Company Profile
-
14.5.2 NeoGenomics , Inc Minimal Residual Disease (MRD) Testing Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 NeoGenomics Laboratories
-
14.6.1 NeoGenomics Laboratories Company Profile
-
14.6.2 NeoGenomics Laboratories Minimal Residual Disease (MRD) Testing Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 ARUP Laboratories
-
14.7.1 ARUP Laboratories Company Profile
-
14.7.2 ARUP Laboratories Minimal Residual Disease (MRD) Testing Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Sysmex Corporation
-
14.8.1 Sysmex Corporation Company Profile
-
14.8.2 Sysmex Corporation Minimal Residual Disease (MRD) Testing Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Opko Health
-
14.9.1 Opko Health Company Profile
-
14.9.2 Opko Health Minimal Residual Disease (MRD) Testing Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Bio-Rad Laboratories
-
14.10.1 Bio-Rad Laboratories Company Profile
-
14.10.2 Bio-Rad Laboratories Minimal Residual Disease (MRD) Testing Market Performance
-
14.10.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Minimal Residual Disease (MRD) Testing Industry Research Conclusions
-
15.2 Minimal Residual Disease (MRD) Testing Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Minimal Residual Disease (MRD) Testing Industry Market Size (2018-2029)
-
Figure China Minimal Residual Disease (MRD) Testing Production Volume, Production Value and Growth Rate of Flow Cytometry (2018-2029)
-
Figure China Minimal Residual Disease (MRD) Testing Production Volume, Production Value and Growth Rate of Liquid Biopsies (2018-2029)
-
Figure China Minimal Residual Disease (MRD) Testing Production Volume, Production Value and Growth Rate of Polymerase Chain Reaction (PCR) (2018-2029)
-
Figure China Minimal Residual Disease (MRD) Testing Production Volume, Production Value and Growth Rate of Next-Generation Sequencing (NGS) (2018-2029)
-
Figure China Minimal Residual Disease (MRD) Testing Sales Volume, Sales Value and Growth Rate of Diagnostic Laboratories (2018-2029)
-
Figure China Minimal Residual Disease (MRD) Testing Sales Volume, Sales Value and Growth Rate of Research Institutions (2018-2029)
-
Figure China Minimal Residual Disease (MRD) Testing Sales Volume, Sales Value and Growth Rate of Specialty Clinics and Hospitals (2018-2029)
-
Figure North China Minimal Residual Disease (MRD) Testing Market Size and Growth Rate from 2018-2029
-
Figure Central China Minimal Residual Disease (MRD) Testing Market Size and Growth Rate from 2018-2029
-
Figure South China Minimal Residual Disease (MRD) Testing Market Size and Growth Rate from 2018-2029
-
Figure East China Minimal Residual Disease (MRD) Testing Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Minimal Residual Disease (MRD) Testing Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Minimal Residual Disease (MRD) Testing Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Minimal Residual Disease (MRD) Testing Market Size and Growth Rate from 2018-2029
-
Figure Minimal Residual Disease (MRD) Testing Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Minimal Residual Disease (MRD) Testing Market Share by Type in 2018
-
Figure China Minimal Residual Disease (MRD) Testing Market Share by Type in 2023
-
Figure China Minimal Residual Disease (MRD) Testing Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Minimal Residual Disease (MRD) Testing Production Volume and Growth Rate of Flow Cytometry (2018-2023)
-
Figure China Minimal Residual Disease (MRD) Testing Production Volume and Growth Rate of Liquid Biopsies (2018-2023)
-
Figure China Minimal Residual Disease (MRD) Testing Production Volume and Growth Rate of Polymerase Chain Reaction (PCR) (2018-2023)
-
Figure China Minimal Residual Disease (MRD) Testing Production Volume and Growth Rate of Next-Generation Sequencing (NGS) (2018-2023)
-
Figure China Minimal Residual Disease (MRD) Testing Market Share by Application in 2018
-
Figure China Minimal Residual Disease (MRD) Testing Market Share by Application in 2023
-
Figure China Minimal Residual Disease (MRD) Testing Total Market Size and Growth Rate from Consumption End
-
Figure China Minimal Residual Disease (MRD) Testing Market Size and Growth Rate of Diagnostic Laboratories (2018-2023)
-
Figure China Minimal Residual Disease (MRD) Testing Market Size and Growth Rate of Research Institutions (2018-2023)
-
Figure China Minimal Residual Disease (MRD) Testing Market Size and Growth Rate of Specialty Clinics and Hospitals (2018-2023)
-
Table China Minimal Residual Disease (MRD) Testing Production Volume by Region (2018-2023)
-
Table China Minimal Residual Disease (MRD) Testing Production Volume Share by Region (2018-2023)
-
Figure China Minimal Residual Disease (MRD) Testing Production Volume Share by Region (2018-2023)
-
Table China Minimal Residual Disease (MRD) Testing Production Value by Region (2018-2023)
-
Table China Minimal Residual Disease (MRD) Testing Production Value Share by Region (2018-2023)
-
Figure China Minimal Residual Disease (MRD) Testing Production Value Share by Region (2018-2023)
-
Table China Minimal Residual Disease (MRD) Testing Sales Volume by Region (2018-2023)
-
Table China Minimal Residual Disease (MRD) Testing Sales Volume Share by Region (2018-2023)
-
Figure China Minimal Residual Disease (MRD) Testing Sales Volume Share by Region (2018-2023)
-
Table China Minimal Residual Disease (MRD) Testing Sales Value by Region (2018-2023)
-
Table China Minimal Residual Disease (MRD) Testing Sales Value Share by Region (2018-2023)
-
Figure China Minimal Residual Disease (MRD) Testing Sales Value Share by Region (2018-2023)
-
Table North China Minimal Residual Disease (MRD) Testing Production Volume by Type (2018-2023)
-
Table North China Minimal Residual Disease (MRD) Testing Production Volume Share by Type (2018-2023)
-
Figure North China Minimal Residual Disease (MRD) Testing Production Volume Share by Type (2018-2023)
-
Table North China Minimal Residual Disease (MRD) Testing Sales Volume by Application (2018-2023)
-
Table North China Minimal Residual Disease (MRD) Testing Sales Volume Share by Application (2018-2023)
-
Figure North China Minimal Residual Disease (MRD) Testing Sales Volume Share by Application (2018-2023)
-
Table Central China Minimal Residual Disease (MRD) Testing Production Volume by Type (2018-2023)
-
Table Central China Minimal Residual Disease (MRD) Testing Production Volume Share by Type (2018-2023)
-
Figure Central China Minimal Residual Disease (MRD) Testing Production Volume Share by Type (2018-2023)
-
Table Central China Minimal Residual Disease (MRD) Testing Sales Volume by Application (2018-2023)
-
Table Central China Minimal Residual Disease (MRD) Testing Sales Volume Share by Application (2018-2023)
-
Figure Central China Minimal Residual Disease (MRD) Testing Sales Volume Share by Application (2018-2023)
-
Table South China Minimal Residual Disease (MRD) Testing Production Volume by Type (2018-2023)
-
Table South China Minimal Residual Disease (MRD) Testing Production Volume Share by Type (2018-2023)
-
Figure South China Minimal Residual Disease (MRD) Testing Production Volume Share by Type (2018-2023)
-
Table South China Minimal Residual Disease (MRD) Testing Sales Volume by Application (2018-2023)
-
Table South China Minimal Residual Disease (MRD) Testing Sales Volume Share by Application (2018-2023)
-
Figure South China Minimal Residual Disease (MRD) Testing Sales Volume Share by Application (2018-2023)
-
Table East China Minimal Residual Disease (MRD) Testing Production Volume by Type (2018-2023)
-
Table East China Minimal Residual Disease (MRD) Testing Production Volume Share by Type (2018-2023)
-
Figure East China Minimal Residual Disease (MRD) Testing Production Volume Share by Type (2018-2023)
-
Table East China Minimal Residual Disease (MRD) Testing Sales Volume by Application (2018-2023)
-
Table East China Minimal Residual Disease (MRD) Testing Sales Volume Share by Application (2018-2023)
-
Figure East China Minimal Residual Disease (MRD) Testing Sales Volume Share by Application (2018-2023)
-
Table Northeast China Minimal Residual Disease (MRD) Testing Production Volume by Type (2018-2023)
-
Table Northeast China Minimal Residual Disease (MRD) Testing Production Volume Share by Type (2018-2023)
-
Figure Northeast China Minimal Residual Disease (MRD) Testing Production Volume Share by Type (2018-2023)
-
Table Northeast China Minimal Residual Disease (MRD) Testing Sales Volume by Application (2018-2023)
-
Table Northeast China Minimal Residual Disease (MRD) Testing Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Minimal Residual Disease (MRD) Testing Sales Volume Share by Application (2018-2023)
-
Table Southwest China Minimal Residual Disease (MRD) Testing Production Volume by Type (2018-2023)
-
Table Southwest China Minimal Residual Disease (MRD) Testing Production Volume Share by Type (2018-2023)
-
Figure Southwest China Minimal Residual Disease (MRD) Testing Production Volume Share by Type (2018-2023)
-
Table Southwest China Minimal Residual Disease (MRD) Testing Sales Volume by Application (2018-2023)
-
Table Southwest China Minimal Residual Disease (MRD) Testing Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Minimal Residual Disease (MRD) Testing Sales Volume Share by Application (2018-2023)
-
Table Northwest China Minimal Residual Disease (MRD) Testing Production Volume by Type (2018-2023)
-
Table Northwest China Minimal Residual Disease (MRD) Testing Production Volume Share by Type (2018-2023)
-
Figure Northwest China Minimal Residual Disease (MRD) Testing Production Volume Share by Type (2018-2023)
-
Table Northwest China Minimal Residual Disease (MRD) Testing Sales Volume by Application (2018-2023)
-
Table Northwest China Minimal Residual Disease (MRD) Testing Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Minimal Residual Disease (MRD) Testing Sales Volume Share by Application (2018-2023)
-
Table Mission Bio Company Profile
-
Table Mission Bio Minimal Residual Disease (MRD) Testing Revenue, Price and Gross (2018-2023)
-
Table Guardant Health Company Profile
-
Table Guardant Health Minimal Residual Disease (MRD) Testing Revenue, Price and Gross (2018-2023)
-
Table Asuragen Company Profile
-
Table Asuragen Minimal Residual Disease (MRD) Testing Revenue, Price and Gross (2018-2023)
-
Table Quest Diagnostics Company Profile
-
Table Quest Diagnostics Minimal Residual Disease (MRD) Testing Revenue, Price and Gross (2018-2023)
-
Table NeoGenomics , Inc Company Profile
-
Table NeoGenomics , Inc Minimal Residual Disease (MRD) Testing Revenue, Price and Gross (2018-2023)
-
Table NeoGenomics Laboratories Company Profile
-
Table NeoGenomics Laboratories Minimal Residual Disease (MRD) Testing Revenue, Price and Gross (2018-2023)
-
Table ARUP Laboratories Company Profile
-
Table ARUP Laboratories Minimal Residual Disease (MRD) Testing Revenue, Price and Gross (2018-2023)
-
Table Sysmex Corporation Company Profile
-
Table Sysmex Corporation Minimal Residual Disease (MRD) Testing Revenue, Price and Gross (2018-2023)
-
Table Opko Health Company Profile
-
Table Opko Health Minimal Residual Disease (MRD) Testing Revenue, Price and Gross (2018-2023)
-
Table Bio-Rad Laboratories Company Profile
-
Table Bio-Rad Laboratories Minimal Residual Disease (MRD) Testing Revenue, Price and Gross (2018-2023)
-
